Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi

Human Pathology

Volumn 30, Issue 5, 1999, Pages 506-512

  Murphy, George F ^a   Mihm Jr , Martin C ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CYTOLOGY; DERMOEPIDERMAL JUNCTION; DYSPLASTIC NEVUS; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; PATHOLOGIST; TUMOR GROWTH;

EID: 0032957132     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90192-2     Document Type: Article

References (31)

1. Clark WH Jr, Reimer RR, Greene M, et al: Origin of familial melanomas from heritable melanocytic lesions. "The B-K mole syndrome." Arch Dermatol 114:732-738, 1978
2. Piepkorn M, Meyer LJ, Goldgar D, et al: The dysplastic melanocytic nevus: A prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 20:407-415, 1989
3. Massi D, Nielsen T, Ackerman AB: Melanocytic dysplasia, dysplastic nevus, and dysplastic nevus syndrome: Myth! Dermatopathol Pract Cone 3:38-59, 1997
4. Elder DE, Murphy GF: Atlas of Tumor Pathology: Melanocytic Tumors of the Skin, Fascicle 2 (ed 3). Washington, DC, Armed Forces Institute of Pathology, 1991, p 78
5. Rhodes AR, Weinstock MA, Fitzpatrick TB, et al: Risk factors for cutaneous melanoma: A practical method for recognizing predisposed individuals. JAMA 258:3146-3154, 1987
6. Elder DE, Goldman LI, Goldman SC, et al: Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma. Cancer 46:1787-1794, 1980
7. Greene MH, Clark WH Jr, Tucker MA, et al: High risk of malignant melanoma-prone families with dysplastic nevi. Ann Intern Med 102:458-465, 1985
8. Lynch HT, Fricho BC III, Lynch J, et al: Family studies of malignant and associated cancer. Surg Gynecol Obstet 141:517, 1975
9. Lynch HT, Fricho BS III, Lynch JF: Familial atypical multiple mole-melanoma syndrome. J Med Genet 15:352, 1978
10. Bale SJ, Dracopoli NC, Tucker MA, et al: Mapping the gene for hereditary cutaneous melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 320:1367-1372, 1989
11. Kraemer KH, Greene MH, Tarone R: Dysplastic nevus and cutaneous melanoma risk. N Engl J Med 315:1615, 1987 (letter)
12. Clark WH Jr, Elder DE, Guerry D IV, et al: A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. HUM PATHOL 15:1147-1165, 1984
13. Crutcher WA, Sagebiel RW: Prevalence of dysplastic naevi in a community practice. Lancet 1:729, 1984 (letter)
14. Holly EA, Kelly JW, Shpall SN, et al: Number of melanocytic nevi as a risk factor for malignant melanoma. J Am Acad Dermatol 17:159-168, 1987
15. Rigel DS, Rivers JK, Kopf AW, et al: Dysplastic nevi: Markers of increased risk for melanoma. Cancer 63:386-389, 1989
16. McGovern VJ: Melanoma: Histologic Diagnosis and Prognosis. New York, NY, Raven Press, 1984, pp 3-24
17. Clark WH Jr, Elder DE, Guerry D IV: The pathogenesis and pathology of dysplastic nevi and malignant melanoma, in Farmer ER, Hood AF (eds): Pathology of the Skin. East Norwalk, CT, Appleton and Lange, 1990
18. Vasen HF, Bergman W, van Haeringen A, et al: The familial dysplastic nevus syndrome: Natural history and the impact of screening on prognosis: A study of nine families in the Netherlands. Eur J Cancer Clin Oncol 25:337-341, 1989
19. Caporaso N, Greene MH, Tsai S, et al: Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: Is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet 24:299-314, 1987
20. Jaspers NG, Roza de Jongh EJ, Donselaar IG, et al: Sister chromatid exchanges, hyperdiploidy and chromosomal rearrangements studied in cells for melanoma-prone individuals belonging to families with the dysplastic nevus syndrome. Cancer Genet Cytogenet 24:33-43, 1987
21. Smoller BR, McNutt NS, Hsu A: HMB-45 staining of dysplastic nevi: Support for a spectrum of progression toward melanoma. Am J Surg Pathol 13:680-684, 1989
22. Elder DE, Rodeck U, Thurin J, et al: Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res 49:5091-5096, 1989
23. Smoller BR, Krueger J: Detection of cytokine-induced protein gamma-immune protein-10 (gamma-IP 10) in atypical melanocytic proliferations. J Am Acad Dermatol 25:627-631, 1991
24. Langer K, Rappersberger K, Steiner A, et al: The ultrastructure of dysplastic naevi: Comparison with superficial spreading melanoma and common nevocellular naevi. Arch Dermatol Res 282:353-362, 1990
25. Rhodes AR, Mihm MC Jr, Weinstock MA: Dysplastic melanocytic nevi: A reproducible histologic definition emphasizing cellular morphology. Mod Pathol 2:306-319, 1989
26. Tong AK, Murphy GF, Mihm MC Jr: Dysplastic nevus: A formal histogenetic precursor of malignant melanoma, in Mihm MC Jr, Murphy GF, Kaufman N (eds): Pathobiology and Recognition of Malignant Melanoma. Baltimore, MD, Williams and Wilkins, 1988, pp 10-18
27. Piepkorn M: A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi. Arch Dermatol 126:514-518, 1990
28. Weinstock MA, Barnhill RL, Rhodes AR, et al: Reliability of the histologic diagnosis of melanocytic dysplasia: The Dysplastic Nevus Panel. Arch Dermatol 133:953-958, 1997
29. Duncan LM, Berwick M, Bruijn JA, et al: Histopathologic recognition and grading of dysplastic melanocytic nevi: An interobserver agreement study. J Invest Dermatol 100:318S-321S, 1993
30. Piepkorn MW, Barnhill RL, Cannon-Albright LA, et al: A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 30:707-710, 1994
31. Magnana-Garcia M, Ackerman AB: Naming acquired melanocytic nevi: Unna's, Meischer's, Spitz's, Clark's. Am J Dermatopathol 12:193-209, 1990